Sort
326,823 grants matching “clinical trial”
Mayo Clinic SPORE in Ovarian Cancer
$2,150,500Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2013 · CA
SPORE: Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
$2,150,500Eric P Winer · Dana-Farber Cancer Inst · P50 · FY2013 · CA
RPCI-UPCI Ovarian Cancer SPORE
$2,150,500Kunle O Odunsi · Roswell Park Cancer Institute Corp · P50 · FY2013 · CA
UAB / UMN SPORE in Pancreatic Cancer
$2,150,500Donald J Buchsbaum · University Of Alabama At Birmingham · P50 · FY2013 · CA
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia
$2,150,500Hagop Kantarjian · University Of Tx Md Anderson Can Ctr · P50 · FY2013 · CA
SPORE in Skin Cancer
$2,150,500John Munn Kirkwood · University Of Pittsburgh At Pittsburgh · P50 · FY2013 · CA
Mayo Clinic Breast Cancer SPORE
$2,150,500Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2013 · CA
M. D. Anderson Cancer Center SPORE in Multiple Myeloma
$2,150,500Robert Zygmunt Orlowski · University Of Tx Md Anderson Can Ctr · P50 · FY2013 · CA
Pacific Ovarian Cancer Research Consortium
$2,150,499Charles Drescher · Fred Hutchinson Cancer Research Center · P50 · FY2013 · CA
Experimental Therapeutics of Leukemia
$2,150,499John C Byrd · Ohio State University · P50 · FY2013 · CA
Targeted antigen receptor treatment of cancer
$2,150,453Alan N. Houghton · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA
Alzheimer's dementia onset and progression in international cohorts (Amended)
$2,150,430Colin Masters · University Of Melbourne · R01 · FY2019 · AG
Assessing the effectiveness of oral anticoagulants in patients with atrial fibrillation at high risk of underutilization due to dementia, recurrent falls, or poor anticoagulation quality
$2,150,379Joshua K Lin · Brigham And Women'S Hospital · RF1 · FY2019 · AG
Development Of A Multicomponent HIV-1 Recombinant Adenoviral Vector Vaccine
$2,149,913Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2012 · AI
Development And Production Of A Multiclade HIV-1 DNA Plasmid Vaccine
$2,149,913Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2012 · AI
SPORE in Gastrointestinal Cancer
$2,149,769Joel E Tepper · Univ Of North Carolina Chapel Hill · P50 · FY2007 · CA
SPORE in Gastrointestinal Cancer
$2,149,769Joel E Tepper · Univ Of North Carolina Chapel Hill · P50 · FY2008 · CA
HIV Centers for Underrepresented Populations in Research Clinical Trials Unit (CURE CTU)
$2,149,542Stephen A Spector · University Of California, San Diego · UM1 · FY2023 · AI
The Heart Outcomes for Pregnancy Expectations Study
$2,149,251John A Spertus · University Of Missouri Kansas City · R01 · FY2025 · HL
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
$2,149,233Peter Karl Sorger · Harvard Medical School · U54 · FY2020 · CA
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$2,149,178Stephen A Spector · University Of California, San Diego · UM1 · FY2018 · AI
Cancer Center Support Grant
$2,149,175Ruben A Mesa · Wake Forest University Health Sciences · P30 · FY2024 · CA
Advancing KNX100 for the treatment of opioid withdrawal: preclinical efficacy and toxicology, and a phase 1 clinical program.
$2,149,117Hugh William Alsop · Kinoxis Therapeutics Pty Ltd · UH3 · FY2023 · DA
Elafin Therapy for Lung Diseases
$2,149,054Marlene Rabinovitch · Stanford University · P01 · FY2012 · HL
Modulating brain plasticity in rehabilitation of stroke and other brain lesions
$2,149,011Leonardo G. Cohen · National Institute Of Neurological Disorders And Stroke · ZIA · FY2013 · NS